Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
17.81
0.18 (1.02%)
At close: Aug 15, 2025, 3:59 PM
17.97
0.90%
After-hours: Aug 15, 2025, 07:56 PM EDT
Beam Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 60.27M | 63.58M | 63.52M | 349.64M | 352.57M | 360.91M | 377.71M | 81.55M | 80.16M | 76.7M | 60.92M | 91.95M | 76.92M | 60.27M | 51.84M | 781K | 24K | 24K |
Cost of Revenue | 5.54M | 5.58M | 11.01M | 16.37M | 23.84M | 25.56M | 27.13M | 27.95M | 105.77M | 103.99M | 102.25M | 101.08M | 70.42M | 110.48M | 295.32M | 328.33M | 301.54M | 275.31M |
Gross Profit | 2.22M | 5.49M | n/a | 327.8M | 328.72M | 335.35M | 350.58M | 53.6M | -25.61M | -27.29M | -41.33M | -9.13M | 6.5M | -50.21M | -243.48M | -327.55M | -301.51M | -275.29M |
Operating Income | -445.98M | -430.72M | -415.57M | -182.67M | -184.44M | -181.69M | -176.49M | -398.33M | -381.36M | -361.18M | -338.48M | -312.98M | -291.31M | -268.32M | -392.46M | -369.78M | -337.47M | -304.78M |
Interest Income | 35.38M | 23.05M | 34.9M | 36.04M | 36.61M | 48.56M | 46.68M | 42.22M | 34.51M | 22.55M | 12.59M | 4.98M | n/a | n/a | n/a | 35K | 204K | 971K |
Pretax Income | -398.58M | -387.3M | -376.7M | -142.19M | -141.61M | -133.37M | -131.16M | -312.67M | -323.75M | -312.92M | -285.68M | -313.04M | -233.99M | -238.29M | -370.64M | -401.39M | -407.73M | -365.69M |
Net Income | -398.58M | -387.34M | -376.74M | -143.59M | -143.01M | -134.74M | -120.1M | -301.24M | -314.73M | -280.45M | -251.62M | -277.84M | -196.38M | -224.14M | -370.5M | -401.39M | -407.73M | -365.69M |
Selling & General & Admin | 104.44M | 107.17M | 100.52M | 109.75M | 108.65M | 109.25M | 111.45M | 96.24M | 92.64M | 92.05M | 87.81M | 82.9M | 76.86M | 66.2M | 57.22M | 47.8M | 39.53M | 33.07M |
Research & Development | 396.28M | 381.56M | 367.56M | 406.19M | 411.99M | 422.55M | 437.38M | 383.64M | 368.88M | 345.83M | 311.59M | 322.03M | 291.37M | 262.39M | 387.09M | 322.76M | 297.96M | 271.74M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -305K | -305K | -305K | -305K |
Operating Expenses | 500.71M | 488.72M | 468.08M | 515.95M | 520.63M | 531.81M | 548.83M | 479.88M | 461.52M | 437.88M | 399.4M | 404.93M | 368.23M | 328.59M | 444.31M | 370.56M | 337.49M | 304.8M |
Interest Expense | 12.33M | 14.19M | 14.19M | 14.19M | 14.19M | 11.95M | 21.91M | 29.52M | 29.52M | 19.63M | 10.31M | 2.7M | 2.71M | 705K | 61K | 1.63M | 1.79M | 2.25M |
Selling & Marketing Expenses | n/a | -5.58M | -11.01M | -16.37M | -16.37M | -10.79M | -5.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 506.25M | 494.3M | 479.09M | 532.32M | 537M | 542.6M | 554.19M | 479.88M | 461.52M | 437.88M | 399.4M | 404.93M | 368.23M | 328.59M | 444.31M | 370.56M | 337.49M | 304.8M |
Income Tax Expense | n/a | 39K | 39K | 1.41M | 1.41M | 1.37M | -11.06M | -11.43M | -9.02M | -32.47M | -34.06M | -35.2M | -37.61M | -14.16M | 748K | 882K | 882K | 882K |
Shares Outstanding (Basic) | 102M | 87.97M | 82.82M | 82.41M | 82.31M | 81.7M | 80.86M | 79.02M | 76.34M | 72.27M | 70.78M | 70.34M | 70.21M | 68.7M | 67.99M | 66.38M | 62.21M | 60.21M |
Shares Outstanding (Diluted) | 102M | 87.97M | 82.82M | 82.41M | 82.31M | 81.7M | 82.7M | 79.02M | 76.34M | 72.27M | 70.78M | 70.34M | 70.21M | 68.7M | 67.99M | 66.38M | 62.21M | 60.21M |
EPS (Basic) | -4.5 | -4.61 | -4.58 | -1.72 | -1.77 | -1.74 | -1.69 | -4 | -4.34 | -3.95 | -3.59 | -4 | -2.86 | -3.4 | -5.95 | -6.59 | -6.86 | -6.32 |
EPS (Diluted) | -4.5 | -4.61 | -4.58 | -1.76 | -1.81 | -1.78 | -1.73 | -4 | -4.34 | -3.95 | -3.59 | -4 | -2.86 | -3.4 | -5.95 | -6.59 | -6.86 | -6.32 |
EBITDA | -396.47M | -399.03M | -383.98M | -160.83M | -162.88M | -160.89M | -156.47M | -379.73M | -364.48M | -345.7M | -324.33M | -298.98M | -279.03M | -257.79M | -382.68M | -362.52M | -330.74M | -298.57M |
EBIT | -418.44M | -421.04M | -405.88M | -171.37M | -173.13M | -170.38M | -165.18M | -398.33M | -381.36M | -361.18M | -338.48M | -314.2M | -292.53M | -269.54M | -393.69M | -369.78M | -337.47M | -304.78M |
Depreciation & Amortization | 21.98M | 22.02M | 21.93M | 21.84M | 23.84M | 25.56M | 27.13M | 27.95M | 23.95M | 22.18M | 20.43M | 19.27M | 19.61M | 17.97M | 16.47M | 12.72M | 10.12M | 7.39M |